Mechanisms of Estrogen-Induced Venous ThromboembolismTCHAIKOVSKI, Svetlana N; ROSING, Jan.Thrombosis research. 2010, Vol 126, Num 1, pp 5-11, issn 0049-3848, 7 p.Article

Protein S as Cofactor for TFPIHACKENG, Tilman M; ROSING, Jan.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 12, pp 2015-2020, issn 1079-5642, 6 p.Article

Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balanceSERE, Kristin M; ROSING, Jan; HACKENG, Tilman M et al.Blood. 2004, Vol 104, Num 12, pp 3624-3630, issn 0006-4971, 7 p.Article

An assay to quantify the two plasma isoforms of factor VHOEKEMA, Lico; ROSING, Jan; TANS, Guido et al.Thrombosis and haemostasis. 2000, Vol 84, Num 6, pp 1066-1071, issn 0340-6245Article

Oral contraceptives, thrombosis and haemostasis : Third Symposium of the Wim Schellekens Foundation: Thrombophilia and ReproductionROSING, Jan; CURVERS, Joyce; TANS, Guido et al.European journal of obstetrics, gynecology, and reproductive biology. 2001, Vol 95, Num 2, pp 193-197, issn 0301-2115Article

Classification and nomenclature of prothrombin activators isolated from snake venoms : On behalf of the Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisMANJUNATHA KINI, R; MORITA, Takashi; ROSING, Jan et al.Thrombosis and haemostasis. 2001, Vol 86, Num 2, pp 710-711, issn 0340-6245Article

Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levelsBRUGGE, Jeroen M; TANS, Guido; ROSING, Jan et al.Thrombosis and haemostasis. 2006, Vol 95, Num 2, pp 236-242, issn 0340-6245, 7 p.Article

Activation of factor V by venom proteasesNICOLAES, Gerry A. F; ROSING, Jan.Toxin reviews (Print). 2006, Vol 25, Num 3, pp 217-234, issn 1556-9543, 18 p.Article

Factor V Leiden: a disorder of factor V anticoagulant functionCASTOLDI, Elisabetta; ROSING, Jan.Current opinion in hematology. 2004, Vol 11, Num 3, pp 176-181, issn 1065-6251, 6 p.Article

Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Ischemic Stroke due to Postmenopausal Hormone TherapyROSSOUW, Jacques E; JOHNSON, Karen C; MANSON, Joann E et al.Stroke (1970). 2012, Vol 43, Num 4, pp 952-957, issn 0039-2499, 6 p.Article

Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiencyCASTOLDI, Elisabetta; MAURISSEN, Lisbeth F. A; TORMENE, Daniela et al.Haematologica (Roma). 2010, Vol 95, Num 9, pp 1563-1571, issn 0390-6078, 9 p.Article

Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsiaNAP, Annemiek W; HAMULYAK, Karly; VAN OERLE, Rene et al.European journal of obstetrics, gynecology, and reproductive biology. 2004, Vol 113, Num 1, pp 26-30, issn 0301-2115, 5 p.Article

The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutationKOENEN, Rory R; TANS, Guido; VAN OERLE, René et al.Blood. 2003, Vol 102, Num 5, pp 1686-1692, issn 0006-4971, 7 p.Article

Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance testCURVERS, Joyce; THOMASSEN, M. Christella L. G. D; RIMMER, Janet et al.Thrombosis and haemostasis. 2002, Vol 88, Num 1, pp 5-11, issn 0340-6245Article

Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsiaTCHAIKOVSKI, Svetlana N; THOMASSEN, M. Christella L. G. D; COSTA, Serban-Dan et al.Thrombosis and haemostasis. 2011, Vol 106, Num 5, pp 914-921, issn 0340-6245, 8 p.Article

The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC)VAN VLIET, Huib A. A. M; TCHAIKOVSKI, Svetlana N; ROSENDAAL, Frits R et al.Thrombosis and haemostasis. 2009, Vol 101, Num 4, pp 691-695, issn 0340-6245, 5 p.Article

Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivationMAURISSEN, Lisbeth F. A; CHRISTELLA, M; THOMASSEN, L. G. D et al.Blood. 2008, Vol 111, Num 6, pp 3034-3041, issn 0006-4971, 8 p.Article

Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiencyDUCKERS, Connie; SIMIONI, Paolo; SPIEZIA, Luca et al.Blood. 2008, Vol 112, Num 9, pp 3615-3623, issn 0006-4971, 9 p.Article

APC resistance during the normal menstrual cycleVAN ROOIJEN, Marianne; SILVEIRA, Angela; THOMASSEN, Stella et al.Thrombosis and haemostasis. 2007, Vol 98, Num 6, pp 1246-1251, issn 0340-6245, 6 p.Article

Protein S multimers are generated in vitro and affect protein S structure-function analysesSERE, Kristin M; WILLEMS, George M; ROSING, Jan et al.Seminars in hematology. 2006, Vol 43, Num 1, pp S111-S120, issn 0037-1963, SUP1Conference Paper

Reduced factor V concentration and altered FV₁/FV₂ ratio do not fully explain R2-associated APC-resistanceGOVERS-RIEMSLAG, Jose W. P; CASTOLDI, Elisabetta; NICOLAES, Gerry A. F et al.Thrombosis and haemostasis. 2002, Vol 88, Num 3, pp 444-449, issn 0340-6245, 6 p.Article

Thrombin generation as an intermediate phenotype for venous thrombosis: A proof-of-concept studySEGERS, Olivier; VAN OERLE, René; TEN CATE, Hugo et al.Thrombosis and haemostasis. 2010, Vol 103, Num 1, pp 114-122, issn 0340-6245, 9 p.Article

Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogensVAN VLIET, Huib A. A. M; FROLICH, Marijke; THOMASSEN, M. Christella L. G. D et al.Human reproduction (Oxford. Print). 2005, Vol 20, Num 2, pp 563-568, issn 0268-1161, 6 p.Article

Effect of oral contraceptives on the anticoagulant activity of protein S in plasmaKOENEN, Rory R; CHRISTELLA, M; THOMASSEN, L. G. D et al.Thrombosis and haemostasis. 2005, Vol 93, Num 5, pp 853-859, issn 0340-6245, 7 p.Article

The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activitiesKOENEN, Rory R; GOMES, Lucio; TANS, Guido et al.Thrombosis and haemostasis. 2004, Vol 91, Num 6, pp 1105-1114, issn 0340-6245, 10 p.Article